Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 2/20 | 0.32 |
| ▸ | F13A1 | P00488 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TGM1 | P22735 | 1/20 | 0.32 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3011297 | 0.80 | CYP2A6 (0.42) | CYP2A6CA1CA2CA5ACA9 | |
| SCHEMBL23536244 | 0.71 | CA1 (0.42) | CYP2A6CA1CA2CA5ACA9 | |
| SCHEMBL6596280 | 0.71 | CYP2A6 (0.38) | CYP2A6CA1CA2CA5ACA9 | |
| SCHEMBL3010421 | 0.71 | CYP2A6 (0.38) | CYP2A6CA1CA2CA5ACA9 | |
| SCHEMBL19997246 | 0.67 | CYP2A6 (0.44) | CYP2A6CA1CA2CA5ACA9 | |
| SCHEMBL18726830 | 0.67 | CA1 (0.34) | CYP2A6CA1CA2CA5ACA9 | |
| SCHEMBL7681435 | 0.66 | ALOX15 (0.52) | TGM2F13A1LMNATGM1TGM3 | |
| SCHEMBL11619282 | 0.66 | KDM4E (0.41) | TGM2F13A1LMNATGM1TGM3 | |
| SCHEMBL32670433 | 0.66 | AR (0.47) | CYP2A6CA1CA2CA5ACA9 | |
| SCHEMBL440244 | 0.64 | CYP2A6 (0.57) | CYP2A6CA1CA2CA5ACA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197950-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | HIGH POINT PHARMACEUTICALS, LLC | 2010-08-05 | — | — | US | claimed |
| EP-2029507-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | High Point Pharmaceuticals, LLC (US) | 2009-03-04 | — | — | EP | claimed |
| WO-2007141295-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | HIGH POINT PHARMACEUTICALS, LLC (US) | 2007-12-13 | — | — | WO | claimed |
| US-20100197950-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | HIGH POINT PHARMACEUTICALS, LLC | 2010-08-05 | — | — | US | disclosed |
| EP-2029507-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | High Point Pharmaceuticals, LLC (US) | 2009-03-04 | — | — | EP | disclosed |
| WO-2007141295-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | HIGH POINT PHARMACEUTICALS, LLC (US) | 2007-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197950-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | HAAO, HPD, PAH | CYP2A6 67/4885CA1 1417/4885CA2 1776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.